← Leaderboards
Anil Shanker
Meharry Medical College
$25,346,519
Attributed
$183,941,323
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $50M · FY2013–25$100M$75M$50M$25M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$183,941,323 · 9
By mechanism
OT2$165,324,995 · 1
S21$6,000,000 · 1
C06$5,981,738 · 1
SC1$3,057,955 · 1
UH3$2,191,378 · 1
UG3$866,227 · 1
Top collaborators
- Paul Avillach8 shared
- Bettina M Beech8 shared
- Evelinn Borrayo8 shared
- Legand L. Burge8 shared
- Alejandra Casillas8 shared
- Harlan Pierre Jones8 shared
- Bradley A. Malin8 shared
- Spero M Manson8 shared
Most similar at Meharry Medical College
Same institution · by research overlap
- Susan A Deriemer$1,515,512
- Stephania T. Miller-Hughes$4,669,499
- Marilyn E. Thompson$776,167
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMalignant NeoplasmsImmuneTumorInnovationBaseMedical SchoolsFundingNeoplastic CellSignal TransductionTumor MicroenvironmentEffector CellImmune ResponseMolecularInflammationCancer CellMediatingChronicTennesseeTissuesDoseLeadAffectLigands
Grant awards (31)
AIM-AHEAD Coordinating Center - All Four Cores$10,000,000
OT2 · FY2025 · OD
AIM-AHEAD Coordinating Center - All Four Cores$6,169,564
OT2 · FY2025 · OD
Meharry Research Facilities for Advanced Genomics (MeRFAG)$5,981,738
C06 · FY2025 · OD · contact PI
Meharry Center for Genome Research (MCGR)$2,191,378
UH3 · FY2025 · HG · contact PI
Endowment for Cardiometabolic Health Disparities Research$2,000,000
S21 · FY2025 · MD · contact PI
AIM-AHEAD Coordinating Center - All Four Cores$45,096,084
OT2 · FY2024 · OD
Endowment for Cardiometabolic Health Disparities Research$2,000,000
S21 · FY2024 · MD · contact PI
AIM-AHEAD Coordinating Center - All Four Cores$1,383,160
OT2 · FY2024 · OD
AIM-AHEAD Coordinating Center - All Four Cores$21,591,214
OT2 · FY2023 · OD
AIM-AHEAD Coordinating Center - All Four Cores$3,417,973
OT2 · FY2023 · OD
Endowment for Cardiometabolic Health Disparities Research$2,000,000
S21 · FY2023 · MD · contact PI
Diversity Center for Genome Research at Meharry$866,227
UG3 · FY2023 · HG · contact PI
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology$66,389
U54 · FY2023 · CA · contact PI
AIM-AHEAD Coordinating Center - All Four Cores$27,667,000
OT2 · FY2022 · OD
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology$59,311
U54 · FY2022 · CA · contact PI
AIM-AHEAD Coordinating Center - All Four Cores$50,000,000
OT2 · FY2021 · OD
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology$47,594
U54 · FY2021 · CA · contact PI
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk$327,375
SC1 · FY2020 · CA · contact PI
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression$75,660
U54 · FY2020 · CA · contact PI
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk$327,375
SC1 · FY2019 · CA · contact PI
Role of Fus1-mediated antitumor CD8T-NK crosstalk in Alzheimer's disease pathology$304,367
SC1 · FY2019 · CA · contact PI
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression$48,088
U54 · FY2019 · CA · contact PI
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk$327,375
SC1 · FY2018 · CA · contact PI
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression$72,040
U54 · FY2018 · CA · contact PI
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk$327,375
SC1 · FY2017 · CA · contact PI
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression$74,288
U54 · FY2017 · CA · contact PI
Defining the effects of bortezomib on NK cell activation in cancer$363,750
SC1 · FY2016 · CA · contact PI
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression$75,660
U54 · FY2016 · CA · contact PI
Defining the effects of bortezomib on NK cell activation in cancer$363,750
SC1 · FY2015 · CA · contact PI
Defining the effects of bortezomib on NK cell activation in cancer$352,838
SC1 · FY2014 · CA · contact PI
Defining the effects of bortezomib on NK cell activation in cancer$363,750
SC1 · FY2013 · CA · contact PI